Insight Molecular Diagnostics Inc. (7OC0)
Munich
2.78
0.00 (0.00%)
Closed
Aug 24, 2026
Day's Range
2.782.78
52 wk Range
2.782.78
Financial Statements - 7OC0 - Insight Molecular Diagnostics Inc.
Revenue
4.05M▲ 115.6%
Net Income
-50.22M▲ 17.2%Net Margin -1238.5%
EBITDA
-27.37M▼ 29.0%
Free Cash Flow
-25.36M▼ 19.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.05M | 1.88M | 1.50M | 958K | 2.19M | 1.21M |
| Cost of Goods | 1.75M | 1.14M | 1.09M | 976K | 778K | 1.85M |
| Gross Profit | 2.29M | 740K | 413K | -18K | 1.42M | -639K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -30.57M | -23.24M | -22.41M | -28.85M | -24M | -33.72M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -19.53M | -37.33M | -2.38M | 10.32M | -28.65M | 2.78M |
| Pre Tax Income | -50.22M | -60.66M | -24.85M | -18.61M | -52.87M | -31.18M |
| Income Tax | - | - | - | 0 | -9.26M | -1.25M |
| Net Income | -50.22M | -60.66M | -27.78M | -72.90M | -64.09M | -29.93M |
| EPS Basic | -1.65 | -4.66 | -3.75 | -20 | -14.4 | -9.2 |
| EPS Diluted | -1.65 | -4.66 | -3.75 | -20 | -14.4 | -9.2 |
| Basic Shares Outstanding | 30.47M | 13.07M | 8.27M | 5.76M | 4.62M | 3.40M |
| Diluted Shares Outstanding | 30.47M | 13.07M | 8.27M | 5.76M | 4.62M | 3.40M |
| Ebit | -50.11M | -60.57M | -24.80M | -18.52M | -52.66M | -30.93M |
| Ebitda | -27.37M | -21.22M | -20.34M | -23.69M | -20.10M | -34.84M |
| Net Income Continuous Operations | -50.22M | -60.66M | -27.78M | -72.90M | -64.09M | -29.93M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | 520K | 0 | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
